Molecular mechanism of the intracellular segments of the melanocortin-4 receptor for NDP-MSH signaling

Biochemistry

Volumn 44, Issue 18, 2005, Pages 6971-6979

  Yang, Yingkui ^a   Chen, Min ^a   Loux, Tara J ^a   Georgeson, Keith E ^a   Harmon, Carroll M ^a  

^a Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; DISEASES; HORMONES; SIGNALING;

HUMAN MELANOCORTIN-4 RECEPTOR (HMC4R); MONOGENIC HUMAN OBESITY; MUTATIONS; RECEPTOR SIGNALING;

BIOCHEMISTRY;

ALPHA INTERMEDIN; CYCLIC AMP; INTERMEDIN; MELANOCORTIN 4 RECEPTOR; NUCLEOSIDE DERIVATIVE; NUCLEOSIDE DIPHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HORMONE BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR MECHANICS; MUTATION; OBESITY; PRIORITY JOURNAL;

ALPHA-MSH; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL LINE; CYCLIC AMP; HUMANS; INTRACELLULAR FLUID; LIGANDS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POINT MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, MELANOCORTIN, TYPE 4; SEQUENCE DELETION; SIGNAL TRANSDUCTION;

EID: 18244401627     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi047521+     Document Type: Article

References (56)

1. Holtkamp, K., Konrad, K., Muller, B., Heussen, N., Herpertz, S., Herpertz-Dahlmann, B., and Hebebrand, J. (2004) Overweight and obesity in children with attention-deficit/hyperactivity disorder, Int. J. Obes. Relat. Metab. Disord. 28, 685-689.
2. Dekkers, J. C., Podolsky, R. H., Treiber, F. A., Barbeau, P., Gutin, B., and Snieder, H. (2004) Development of general and central obesity from childhood into early adulthood in African American and European American males and females with a family history of cardiovascular disease, Am. J. Clin. Nutr. 79, 661-668.
3. Hotu, S., Carter, B., Watson, P., Cutfield, W., and Cundy, T. (2004) Increasing prevalence of type 2 diabetes in adolescents, J. Paediatr. Child Health 40, 201-204.
4. Bhargava, S. K., Sachdev, H. S., Fall, C. H., Osmond, C., Lakshmy, R., Barker, D. J., Biswas, S. K., Ramji, S., Prabhakaran, D., and Reddy, K. S. (2004) Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood, N. Engl. J. Med. 350, 865-875.
5. Nammi, S., Koka, S., Chinnala, K. M., and Boini, K. M. (2004) Obesity: An overview on its current perspectives and treatment options, Nutr. J. 3, 3.
6. Boston, B. A. (2001) Pro-opiomelanocortin and weight regulation: From mice to men, J. Pediatr. Endocrinol. Metab. 14 (supplement 6), 1409-1416.
7. Boutin, P., and Froguel, P. (2001) Genetics of human obesity, Best Pract. Res. Clin. Endocrinol. Metab. 15, 391-404.
8. Hu, Y., Bloomquist, B. T., Cornfield, L. J., DeCarr, L. B., Flores-Riveros, J. R., Friedman, L., Jiang, P., Lewis-Higgins, L., Sadlowski, Y., Schaefer, J., Velazquez, N., and McCaleb, M. L. (1996) Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior, J. Biol. Chem. 271, 26315-26319.
9. Bultman, S. J., Michaud, E. J., and Woychik, R. P. (1992) Molecular characterization of the mouse agouti locus, Cell 71, 1195-1204.
10. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994) Positional cloning of the mouse obese gene and its human homologue, Nature 372, 425-432.
11. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richarson, J. A., Kozlowski, G. P., Wilson, S., Arch, J. R., Buckingham, R. E., Haynes, A. C., Carr, S. A., Annan, R. S., McNulty, D. E., Liu, W. S., Terrett, J. A., Elshourbagy, N. A., Bergsma, D. J., and Yanagisawa, M. (1998) Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior, Cell 92, 1 page following 696.
12. Shimada, M., Tritos, N. A., Lowell, B. B., Flier, J. S., and Maratos-Flier, E. (1998) Mice lacking melanin-concentrating hormone are hypophagic and lean, Nature 396, 670-674.
13. Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., Smith, F. J., Campfield, L. A., Burn, P., and Lee, F. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice, Cell 88, 131-141.
14. Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J., and Cone, R. D. (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome, Nature 385, 165-168.
15. Giraudo, S. Q., Billington, C. J., and Levine, A. S. (1998) Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands, Brain Res. 809, 302-306.
16. Cone, R. D. (1999) The central melanocortin system and energy homeostasis, Trends Endocrinol. Metab. 10, 211-216.
17. Fisher, S. L., Yagaloff, K. A., and Burn, P. (1999) Melanocortin-4 receptor: A novel signalling pathway involved in body weight regulation, Int. J. Obes. Relat. Metab. Disord. 23 (supplement 1), 54-58.
18. Marsh, D. J., Hollopeter, G., Huszar, D., Laufer, R., Yagaloff, K. A., Fisher, S. L., Burn, P., and Palmiter, R. D. (1999) Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides, Nat. Genet. 21, 119-122.
19. Lubrano-Berthelier, C., Cavazos, M., Dubern, B., Shapiro, A., Stunff, C. L., Zhang, S., Picart, F., Govaerts, C., Froguel, P., Bougneres, P., Clement, K., and Vaisse, C. (2003) Molecular genetics of human obesity-associated MC4R mutations, Ann. N. Y. Acad. Sci. 994, 49-57.
20. Farooqi, I. S., Keogh, J. M., Yeo, G. S., Lank, E. J., Cheetham, T., and O'Rahilly, S. (2003) Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene, N. Engl. J. Med. 348, 1085-1095.
21. Farooqi, I. S., Yeo, G. S., Keogh, J. M., Aminian, S., Jebb, S. A., Butler, G., Cheetham, T., and O'Rahilly, S. (2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency, J. Clin. Invest. 106, 271-279.
22. Yeo, G. S., Farooqi, I. S., Aminian, S., Halsall, D. J., Stanhope, R. G., and O'Rahilly, S. (1998) A frameshift mutation in MC4R associated with dominantly inherited human obesity, Nat. Genet. 20, 111-112.
23. Pulakat, L., Gray, A., Johnson, J., Knowle, D., Burns, V., and Gavini, N. (2002) Role of C-terminal cytoplasmic domain of the AT2 receptor in ligand binding and signaling, FEBS Lett 524, 73-78.
24. Perroy, J., Gutierrez, G. J., Coulon, V., Bockaert, J., Pin, J. P., and Fagni, L. (2001) The C terminus of the metabotropic glutamate receptor subtypes 2 and 7 specifies the receptor signaling pathways, J. Biol. Chem. 276, 45800-45805.
25. Pisegna, J. R., Lyu, R. M., and Germano, P. M. (2000) Essential structural motif in the C-terminus of the PACAP type I receptor for signal transduction and internalization, Ann. N. Y. Acad. Sci. 921, 195-201.
26. Lyu, R. M., Germano, P. M., Choi, J. K., Le, S. V., and Pisegna, J. R. (2000) Identification of an essential amino acid motif within the C terminus of the pituitary adenylate cyclase-activating polypeptide type I receptor that is critical for signal transduction but not for receptor internalization, J. Biol. Chem. 275, 36134-36142.
27. Grunewald, S., Schupp, B. J., Ikeda, S. R., Kuner, R., Steigerwald, F., Kornau, H. C., and Kohr, G. (2002) Importance of the γ-aminobutyric acid(B) receptor C-termini for G-protein coupling, Mol. Pharmacol. 61, 1070-1080.
28. Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S. J., del Valle, J., and Yamada, T. (1993) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor, J. Biol. Chem. 268, 15174-15179.
29. van Leeuwen, D., Steffey, M. E., Donahue, C., Ho, G., and MacKenzie, R. G. (2003) Cell surface expression of the melanocortin-4 receptor is dependent on a C-terminal di-isoleucine sequence at codons 316/317, J. Biol. Chem. 278, 15935-15940.
30. Ho, G., and MacKenzie, R. G. (1999) Functional characterization of mutations in melanocortin-4 receptor associated with human obesity, J. Biol. Chem. 274, 35816-35822.
31. Yang, Y. K., Dickinson, C. J., Zeng, Q., Li, J. Y., Thompson, D. A., and Gantz, I. (1999) Contribution of melanocortin receptor exoloops to agouti-related protein binding, J. Biol. Chem. 274, 14100-14106.
32. Tritos, N. A., and Maratos-Flier, E. (1999) Two important systems in energy homeostasis: Melanocortins and melanin-concentrating hormone, Neuropeptides 33, 339-349.
33. Guan, X. M., Kobilka, T. S., and Kobilka, B. K. (1992) Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide, J. Biol. Chem. 267, 21995-21998.
34. 7]-melanocyte stimulating hormone with the human melanocortin-1 receptor, J. Biol. Chem. 272, 23000-23010.
35. Yang, Y. K., Fong, T. M., Dickinson, C. J., Mao, C., Li, J. Y., Tota, M. R., Mosley, R., van der Ploeg, L. H., and Gantz, I. (2000) Molecular determinants of ligand binding to the human melanocortin-4 receptor, Biochemistry 39, 14900-14911.
36. Yang, Y. K., Ollmann, M. M., Wilson, B. D., Dickinson, C., Yamada, T., Barsh, G. S., and Gantz, I. (1997) Effects of recombinant agouti-signaling protein on melanocortin action, Mol. Endocrinol. 11, 274-280.
37. Conrad, D. M., Hanniman, E. A., Watson, C. L., Mader, J. S., and Hoskin, D. W. (2004) Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling, J. Cell. Biochem. 92, 387-399.
38. Cai, K., Itoh, Y., and Khorana, H. G. (2001) Mapping of contact sites in complex formation between transducin and light-activated rhodopsin by covalent crosslinking: Use of a photoactivatable reagent, Proc. Natl. Acad. Sci. U.S.A. 98, 4877-4882.
39. Kristiansen, K. (2004) Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: Molecular modeling and mutagenesis approaches to receptor structure and function, Pharmacol. Ther. 103, 21-80.
40. Gudermann, T., Schoneberg, T., and Schultz, G. (1997) Functional and structural complexity of signal transduction via G-protein-coupled receptors, Annu. Rev. Neurosci. 20, 399-427.
41. Senogles, S. E., Heimert, T. L., Odife, E. R., and Quasney, M. W. (2004) A region of the third intracellular loop of the short form of the D2 dopamine receptor dictates Gi coupling specificity, J. Biol. Chem. 279, 1601-1606.
42. Gether, U. (2000) Uncovering molecular mechanisms involved in activation of G protein-coupled receptors, Endocr. Rev. 21, 90-113.
43. Gantz, I., Shimoto, Y., Konda, Y., Miwa, H., Dickinson, C. J., and Yamada, T. (1994) Molecular cloning, expression, and characterization of a fifth melanocortin receptor, Biochem. Biophys. Res. Commun. 200, 1214-1220.
44. Preisser, L., Ancellin, N., Michaelis, L., Creminon, C., Morel, A., and Corman, B. (1999) Role of the carboxyl-terminal region, dileucine motif and cysteine residues in signalling and internalization of vasopressin V1a receptor, FEBS Lett. 460, 303-308.
45. Hwa, J., Reeves, P. J., Klein-Seetharaman, J., Davidson, F., and Khorana, H. G. (1999) Structure and function in rhodopsin: further elucidation of the role of the intradiscal cysteines, Cys-110, -185, and -187, in rhodopsin folding and function, Proc. Natl. Acad. Sci. U.S.A. 96, 1932-1935.
46. Tarnow, P., Schoneberg, T., Krude, H., Gruters, A., and Biebermann, H. (2003) Mutationally induced disulfide bond formation within the third extracellular loop causes melanocortin 4 receptor inactivation in patients with obesity, J. Biol. Chem. 278, 48666-48673.
47. Lagerstrom, M. C., Klovins, J., Fredriksson, R., Fridmanis, D., Haitina, T., Ling, M. K., Berglund, M. M., and Schioth, H. B. (2003) High affinity agonistic metal ion binding sites within the melanocortin 4 receptor illustrate conformational change of transmembrane region 3, J. Biol. Chem. 278, 51521-51526.
48. Holst, B., Elling, C. E., and Schwartz, T. W. (2002) Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors, J. Biol. Chem. 277, 47662-47670.
49. Shinyama, H., Masuzaki, H., Fang, H., and Flier, J. S. (2003) Regulation of melanocortin-4 receptor signaling: Agonist-mediated desensitization and internalization, Endocrinology 144, 1301-1314.
50. Yang, Y., Chen, M., Lai, Y., Gantz, I., Georgeson, K. E., and Harmon, C. M. (2002) Molecular determinants of human melanocortin-4 receptor responsible for antagonist SHU9119 selective activity, J. Biol. Chem. 277, 20328-20335.
51. Yang, Y., Chen, M., Lai, Y., Gantz, I., Yagmurlu, A., Georgeson, K. E., and Harmon, C. M. (2003) Molecular determination of agouti-related protein binding to human melanocortin-4 receptor, Mol. Pharmacol. 64, 94-103.
52. Haskell-Luevano, C., Cone, R. D., Monck, E. K., and Wan, Y. P. (2001) Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: Identification of agouti-related protein (AGRP), melanocortin agonist, and synthetic peptide antagonist interaction determinants, Biochemistry 40, 6164-6179.
53. Haskell-Luevano, C., Sawyer, T. K., Trumpp-Kallmeyer, S., Bikker, J. A., Humblet, C., Gantz, I., and Hruby, V. J. (1996) Three-dimensional molecular models of the hMC1R melanocortin receptor: Complexes with melanotropin peptide agonists, Drug Des. Discovery 14, 197-211.
54. Dohlman, H. G., Thorner, J., Caron, M. G., and Lefkowitz, R. J. (1991) Model systems for the study of seven-transmembrane-segment receptors, Annu. Rev. Biochem. 60, 653-688.
55. Chicchi, G. G., Graziano, M. P., Koch, G., Hey, P., Sullivan, K., Vicario, P. P., and Cascieri, M. A. (1997) Alterations in receptor activation and divalent cation activation of agonist binding by deletion of intracellular domains of the glucagon receptor, J. Biol. Chem. 272, 7765-7769.
56. Takhar, S., Gyomorey, S., Su, R. C., Mathi, S. K., Li, X., and Wheeler, M. B. (1996) The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system, Endocrinology 137, 2175-2178.